Decheng Capital — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Terns Pharmaceuticalsternspharma.comin𝕏Dec 2020
Terns Pharmaceuticals is a biopharmaceutical company developing therapies, including its TERN-701 program.
BiotechHealthtechFoster City, US
Mark Vignola, Ph.D.(Executive Officer)Bryan Yoon(Executive Officer)Senthil Sundaram(Director, Executive Officer)Weidong Zhong, Ph.D.(Executive Officer, Director)Jill Quigley(Director)David Fellows(Director)
Co-investorsLAVLilly Asia VenturesVivo Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.